Natalie Staplin

PhD

MRC PHRU Senior Statistician

Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.

Recent publications

Lopinavir-ritonavir in Hospitalised Patients with COVID-19 – a randomised, controlled, open-label, platform trial
Journal article

LINSELL L. et al, (2020), The Lancet
CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE
Journal article

HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology
Blood pressure and kidney disease: chicken or egg (or both)?
Journal article

Staplin N. et al, (2020), Kidney Int, 98, 547 - 549
In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
Journal article

Herrington WG. and Staplin N., (2020), Ann Intern Med, 173
In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
Journal article

Herrington WG. and Staplin N., (2020), Ann Intern Med, 173